Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ecklund

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Pediatric Psychology|December 5, 2021
Multimodal Assessment of Medication Adherence Among Youth With Migraine: An Ancillary Study of the CHAMP TrialBrooke L Reidy, Scott W Powers, Christopher S Coffey, et al.
Cephalalgia : an International Journal of Headache|August 18, 2021
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trialBrooke L Reidy, James Peugh, Andrew D Hershey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 15, 2020
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosisRobert A Bermel, Janel K Fedler, Peter Kaiser, et al.
JAMA Network Open|July 12, 2021
Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication TrialScott W Powers, Christopher S Coffey, Leigh A Chamberlin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Pediatric Psychology|December 5, 2021
Multimodal Assessment of Medication Adherence Among Youth With Migraine: An Ancillary Study of the CHAMP TrialBrooke L Reidy, Scott W Powers, Christopher S Coffey, et al.
Cephalalgia : an International Journal of Headache|August 18, 2021
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trialBrooke L Reidy, James Peugh, Andrew D Hershey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 15, 2020
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosisRobert A Bermel, Janel K Fedler, Peter Kaiser, et al.
JAMA Network Open|July 12, 2021
Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication TrialScott W Powers, Christopher S Coffey, Leigh A Chamberlin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Pageof 3